Catabasis Pharmaceuticals (CATB) Stock Climbs in After-Hours Trading After IPO

NEW YORK (TheStreet) -- Catabasis Pharmaceuticals (CATB) shares are climbing 0.92% to $13.12 in after-hours trading on Thursday after the company gained 8.33% to $13 in intraday trading following its initial public offering.

The Cambridge, MA-based clinical stage biopharmaceutical company priced its upsized sale of 5 million shares at $12 per share.

Catabasis, a company that develops technology for improving drug efficacy, priced its IPO below analysts' $13 to $15 expectations.

CATB Price Chart CATB Price data by YCharts

If you liked this article you might like

CEOs Are Dropping Like Flies

North Korea Leader Kim Jong Un Warrants Your Attention, Silly Investor

Domino's Pizza CEO Thinks Self Driving Cars Will Deliver Pizza in 10 Years

Domino's Pizza CEO: In 10 Years,Self-Driving Cars Will Deliver Pizza

Your Guide to Making a Lot of Money on the Driverless Car Boom